This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Events & Webinars

Bayer Oncology HCC Clinical Expert Series

 Nexavar and Stivarga

Description

The Bayer Oncology HCC Clinical Expert Series is a programme of short videos that will cover a range of topical and relevant discussion points covered by leading HCC healthcare professionals in the UK.

  • Tahir Shah v2
    Tahir Shah

In this video, part of the Bayer Oncology HCC Clinical Expert Series, Dr Tahir Shah (Queen Elizabeth Hospital, Birmingham) talks about the importance of liver preservation when treating patients with hepatocellular carcinoma, and how the overuse of Transarterial chemoembolisation (TACE) might further compromise liver function.

  • Sarah Selemani
    Sarah Selemani

In this short video, part of the Bayer Oncology HCC Clinical Expert Series, Sarah Selemani (King’s College Hospital, London) explores the trade-off between symptom management and quality of life when treating patients with hepatocellular carcinoma.

The management and treatment of patients
Nexavar® (sorafenib) | Stivarga® (regorafenib)
HCC Resources
Nexavar® (sorafenib) | Stivarga® (regorafenib)
Oncology Homepage
Welcome to the home of Bayer Oncology
PP-PF-ONC-GB-0398, February 2024

PP-NEX-GB-0218 | February 2024